Quality of life and its association with direct medical costs for COPD in urban China
- PMID: 25972271
- PMCID: PMC4429937
- DOI: 10.1186/s12955-015-0241-5
Quality of life and its association with direct medical costs for COPD in urban China
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death worldwide. Few studies have focused on the quality of life (QoL) associated medical costs for COPD in China.
Methods: A cross-sectional survey of 678 COPD patients was conducted in four major cities (Beijing, Shanghai, Guangzhou and Chengdu), China, in 2011. Data on socio-demographic information, health conditions and medical costs were collected through a face-to-face interview combined with medical record searching. The EuroQol (EQ-5D) health questionnaire was applied to assess the QoL of COPD patients.
Results: Among 678 patients with COPD, nearly 40% had difficulties in mobility, usual activities and pain/discomfort, one third had various degrees of anxiety/depression, and one fifth had difficulties in self-care. The COPD patients had a median utility score of 0.768 and a median visual analog scale score of 70. The degree of difficulties in any dimensions significantly increased, and utility and health scores decreased with severity of the disease. Age, gender and disease severity were significantly associated with the quality of life after taking other covariates into consideration. Poorer QoL was a significant indicator of higher direct medical costs for COPD patients.
Conclusion: Impaired quality of life was significantly linked to increased medical costs for COPD patients and could be an important measure for policy- and decision-making in COPD care.
Similar articles
-
Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?Chest. 2006 Oct;130(4):1117-28. doi: 10.1378/chest.130.4.1117. Chest. 2006. PMID: 17035446 Clinical Trial.
-
COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan.Int J Chron Obstruct Pulmon Dis. 2018 Aug 28;13:2629-2641. doi: 10.2147/COPD.S167476. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30214181 Free PMC article.
-
Quality of life and its associated factors for mild chronic obstructive pulmonary disease patients of urban community settings.Ann Palliat Med. 2020 Jul;9(4):1420-1430. doi: 10.21037/apm-19-655. Epub 2020 Jul 14. Ann Palliat Med. 2020. PMID: 32692206
-
[Impact of chronic obstructive pulmonary disease on quality of life and economic burden in Chinese urban areas].Zhonghua Jie He He Hu Xi Za Zhi. 2009 Apr;32(4):253-7. Zhonghua Jie He He Hu Xi Za Zhi. 2009. PMID: 19576036 Chinese.
-
Do Model-Based Studies in Chronic Obstructive Pulmonary Disease Measure Correct Values of Utility? A Meta-Analysis.Value Health. 2016 Jun;19(4):363-73. doi: 10.1016/j.jval.2016.01.012. Epub 2016 Mar 24. Value Health. 2016. PMID: 27325328 Review.
Cited by
-
Chronic obstructive pulmonary disease patients' quality of life and its related factors: A cross-sectional study of the Jordanian population.F1000Res. 2022 May 26;11:581. doi: 10.12688/f1000research.121783.1. eCollection 2022. F1000Res. 2022. PMID: 35811805 Free PMC article.
-
Pain problems for patients with mild and moderate chronic obstructive pulmonary disease - a community-based study in Shanghai.J Pain Res. 2017 Sep 15;10:2247-2252. doi: 10.2147/JPR.S141940. eCollection 2017. J Pain Res. 2017. PMID: 28979162 Free PMC article.
-
Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies.NPJ Prim Care Respir Med. 2017 Feb 2;27(1):7. doi: 10.1038/s41533-016-0002-x. NPJ Prim Care Respir Med. 2017. PMID: 28154373 Free PMC article. Clinical Trial.
-
A Systematic Literature Review of the Humanistic Burden of COPD.Int J Chron Obstruct Pulmon Dis. 2021 May 10;16:1303-1314. doi: 10.2147/COPD.S296696. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34007170 Free PMC article.
-
Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease.BMC Pulm Med. 2020 Mar 23;20(1):73. doi: 10.1186/s12890-020-1116-z. BMC Pulm Med. 2020. PMID: 32293387 Free PMC article.
References
-
- WHO. The top 10 causes of death. Available: http://www.who.int/mediacentre/factsheets/fs310/en/index.html. Accessed April 11, 2015.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical